These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34272753)

  • 1. PRRX1-NCOA1-rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under-recognised, distinctive mesenchymal tumour.
    Dermawan JK; Azzato EM; Jebastin Thangaiah J; Gjorgova-Gjeorgievski S; Rubin BP; Folpe AL; Agaimy A; Fritchie KJ
    Histopathology; 2021 Dec; 79(6):997-1003. PubMed ID: 34272753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.
    Lacambra MD; Weinreb I; Demicco EG; Chow C; Sung YS; Swanson D; To KF; Wong KC; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2019 Oct; 58(10):705-712. PubMed ID: 31008539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRRX1-fused mesenchymal neoplasm: A novel PRRX1::NCOA1 fusion transcript.
    Cheng X; Wang J; Fang R; Xu J; Wang S; Zhao M
    J Cutan Pathol; 2024 Nov; 51(11):828-833. PubMed ID: 38986510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging PRRX1-NCOA fibroblastic neoplasm: a combined reappraisal of published tumors and two new cases.
    Chen CH; Chang KC; Chuang CH; Fu JT; Huang HY
    Virchows Arch; 2022 Jul; 481(1):111-116. PubMed ID: 34647172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor.
    Cloutier JM; Maloney NS; Wang WL; Lazar AJ
    J Cutan Pathol; 2022 Sep; 49(9):802-807. PubMed ID: 35583270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "PRRX1-rearranged mesenchymal tumors": expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature.
    Warmke LM; Michal M; Martínek P; Agaimy A; Din NU; Perret R; Hostein I; Le Loarer F; Voltaggio L; Gross JM
    Virchows Arch; 2023 Aug; 483(2):207-214. PubMed ID: 37338620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
    Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
    Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
    Mohamed M; Fisher C; Thway K
    Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.
    Folk GS; Williams SB; Foss RB; Fanburg-Smith JC
    Head Neck Pathol; 2007 Sep; 1(1):13-20. PubMed ID: 20614275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases.
    Yin T; Zhu P; Lao IW; Yu L; Bai Q; Zhou X; Wang J
    Histopathology; 2024 Mar; 84(4):661-670. PubMed ID: 38084644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing
    Cordier F; Fadaei S; Ferdinande L; Dochy F; Vanwalleghem L; Van Den Bossche K; Loontiens S; Van der Meulen J; Van Roy N; Van Dorpe J; Creytens D
    J Clin Pathol; 2023 Dec; ():. PubMed ID: 38154915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
    Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
    Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.
    Kinoshita I; Kohashi K; Yamamoto H; Yamada Y; Inoue T; Higaki K; Teramoto N; Oshiro Y; Nakashima Y; Oda Y
    Histopathology; 2021 Oct; 79(4):629-641. PubMed ID: 33932047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiofibroma of soft tissue: a clinicopathologic analysis of 24 cases].
    Xu XL; Liu JG; Sun M; Yu L; Liu QY; Bai QM; Wu LJ; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):616-621. PubMed ID: 30107667
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature.
    Peng Y; Zhang D; Lei T; Xie J; Wu C; Wang H; Shi Y; Li Q; Wang J
    Pathology; 2023 Apr; 55(3):355-361. PubMed ID: 36690575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.